. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Double-Blind MethodDrug Approval/legislation & jurisprudenceHIV Infections/drug therapyHIV Integrase Inhibitors/administration & dosageHIV Integrase Inhibitors/adverse effectsHIV Integrase Inhibitors/therapeutic useHumansOrganic Chemicals/administration & dosageOrganic Chemicals/adverse effectsOrganic Chemicals/therapeutic usePlacebosPyrrolidinonesRaltegravir PotassiumTabletsUnited StatesUnited States Food and Drug Administration
Substances: See more » HIV Integrase InhibitorsOrganic ChemicalsPlacebosPyrrolidinonesTabletsRaltegravir Potassium
Year: 2007 PMID: 18411485
Source DB: PubMed Journal: AIDS Alert ISSN: 0887-0292